Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.10 (0.44%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £234.54m
SCLP Live PriceLast checked at - London Stock Exchange

Intraday Scancell Holdings Share Chart

Scancell Holdings News

Scancell Holdings Raises GBP1.2 Million Via Share Open Offer (ALLISS)
8 May 2018

Scancell Holdings Raises GBP1.2 Million Via Share Open Offer (ALLISS)

LONDON (Alliance News) - Scancell Holdings PLC said Tuesday that it has raised GBP1.2 million through an open offer of 10.1 million shares at a price ...

Hygea VCT Increases NAV Per Share, Changes RBS Overdraft To Loan
3 May 2018

Hygea VCT Increases NAV Per Share, Changes RBS Overdraft To Loan

LONDON (Alliance News) - Hygea VCT PLC said on Thursday its net present value per share increased in the recent quarter.At March 31, Hygea's NAV per s...

UPDATE: Scancell Raises GBP7.5 Million, Makes Antibody Acquisition (ALLISS)
18 Apr 2018

UPDATE: Scancell Raises GBP7.5 Million, Makes Antibody Acquisition (ALLISS)

LONDON (Alliance News) - Immunotherapy developer Scancell Holdings PLC said Wednesday that it raised GBP7.5 million via a placing of 57.4 million shar...

Scancell Announces GBP8 Million Fundraise, Makes Antibody Acquisition (ALLISS)
18 Apr 2018

Scancell Announces GBP8 Million Fundraise, Makes Antibody Acquisition (ALLISS)

LONDON (Alliance News) - Immunotherapy developer Scancell Holdings PLC said Wednesday that it will raise up to GBP8.0 million via equity issue and als...

Scancell Signs Manufacturing Agreement With PolyPeptide Group
3 Apr 2018

Scancell Signs Manufacturing Agreement With PolyPeptide Group

LONDON (Alliance News) - Cancer treatment developer Scancell Holdings PLC said on Tuesday it has signed a manufacturing agreement with therapeutic pep...

Scancell to develop ImmunoBody lung cancer treatment
10 Oct 2016

Scancell to develop ImmunoBody lung cancer treatment

(ShareCast News) - Cancer immunotherapy development company Scancell Holdings announced on Monday its intention to develop its SCIB2 ImmunoBody for th...

Scancell Holdings widens full year loss on US investment
16 Sep 2016

Scancell Holdings widens full year loss on US investment

(ShareCast News) - Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, has reported a third consecutive full year los...